Effect of a Nitric Oxide Donor on Intracellular Cytokine Production in Normal Human Peripheral Lymphocytes by Yamasaki, Akira et al.
7Yonago Acta medica 1998;41:7–15
Effect of a Nitric Oxide Donor on Intracellular Cytokine Production in
Normal Human Peripheral Lymphocytes
Akira Yamasaki, Katsuyuki Tomita and Yutaka Hitsuda
Third Department of Internal Medicine, Faculty of Medicine, Tottori University, Yonago 683-
0826, Japan
It has been recently suggested that nitric oxide (NO) plays an important role in
modulating immune responses including helper T (Th) cell differentiation.  To investigate
the effect of NO on cytokine production in T cells, we examined in vitro the percentage
of interferon (IFN)-γ  and interleukin (IL)-4 producing cells by the intracellular cytokine
staining method with flow cytometry.  The percentage of IFN-γ and IL-4 producing
cells reached maximal value 8 h after stimulation by phorbol 12-myristate 13-acetate
(PMA) and ionomycin.  When an NO donor, sodium nitroprusside (SNP), was co-
incubated with PMA and ionomycin for 8 h, nitrite levels increased in a dose dependent
manner for SNP (P = 0.007; Friedman test). The percentage of IFN-γ producing cells
was diminished in consequence of the increasing doses of SNP (P = 0.002; Friedman
test).  While the percentage of IL-4 producing cells tended to be diminished by SNP,
this difference, however, was statistically not significant (P = 0.062; Friedman test).
Therefore, we have suggested that NO might affect Th cell differentiation through
inhibition of Th1-cytokine production and might cause a Th2 cell predominant state.
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isothiocyanate; IFN-γ, interferon−γ; IL, interleukin; NO, nitric oxide; NOS, NO synthase; PBMC, peripheral
blood mononuclear cell; PE, phycoerythrin; PKA, protein kinase A; PMA, phorbol 12-myristate 13-acetate;
SIN-1, 3-morpholinosydnonimine N-ethylcarbamide; SNP, sodium nitroprusside; Th cell, helper T cell
Nitric oxide (NO) has many biological func-
tions, for example, vasodilation (Palmer et al.,
1987), platelet aggregation (Radomski et al.,
1987), microbicidal activity (Liew, 1993), neuro-
transmitter (Bredt and Snyder, 1994) and inflam-
matory response (Moilanen and Vapaatalo, 1995).
NO also plays an important role in the patho-
physiology of airway diseases as suggested from
measurement of NO in the exhaled air of pa-
tients with airway inflammation.  It has been re-
ported that there was a marked increase in the
concentration of exhaled NO in patients with
bronchiectasis (Kharitonov et al., 1995) and
bronchial asthma (Alving et al., 1993).  For
asthmatic patients, NO may have a beneficial
effect, so far as it is a bronchodilator (Högman
et al., 1993).  However, a high concentration of
NO may have cytotoxic effects on airway epi-
thelial cells and this could contribute to epithe-
lial shedding as described in asthmatic airways
(Kanazawa et al., 1997).
The effect of NO on the function of lympho-
cytes involving T helper (Th) cell differentiation
into Th1 cells, which produce mainly interferon
(IFN)-γ, and/or into Th2 cells, which produce
mainly interleukin (IL)-4, has been of great inter-
est, because the imbalance between Th1- and
Th2-cytokine was one of the pathogenesis of
atopic diseases including asthma (Umetsu and
DeKruyff, 1997).  Taylor-Robinson and col-
leagues (1994) reported that NO inhibited the
proliferation of Th1 cells and the production of
Th1-cytokines but did not affect Th2 cells.  On
the other hand, Bauer and colleagues (1997) re-
ported that NO inhibited the production of both
Th1- and Th2-cytokines from activated human
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T cells.  Thus, the relationship between NO and
Th cell differentiation has not yet been clearly
understood.
Recently, the assessment of intracellular
cytokines has become available.  This method is
suitable for identifying heterogeneous T cells
with respect to cytokine-producing patterns
(Th1 or Th2).  Furthermore, analysis at the
single cell level is enough to estimate cytokine
production for short time cultures (Jung et al,
1993).  On the other hand, the analysis of the
secretion of cytokines in supernatants requires
culturing cells for a longer time (Jung et al,
1993; Gonzalez et al, 1994).  Thus, we consid-
ered that this method was more physiologically
relevant to study the relationship between NO
and Th cell differentiation.  NO is generated
from L-arginine by NO synthases (NOS)
(Nathan and Xie, 1994) in vivo, while in vitro
chemical compounds such as sodium nitro-
prusside (SNP) and 3-morpholinosydnonimine
N-ethylcarbamide (SIN-1) spontaneously
release NO in aqueous solution and have been
used as NO donors.
In this study, we investigated the effect of
the NO donor on the production of intracellular
IFN-γ and IL-4 in lymphocytes.
Materials and Methods
Preparation of peripheral blood mono-
nuclear cells
Peripheral venous blood was collected into
heparinized tubes from 8 healthy subjects, 4
males and 4 females.  The average age of the 8
subjects was 34.7 years.  Peripheral blood
mononuclear cells (PBMCs) were isolated by
Ficoll-Hypaque (specific gravity 1.077 g/mL)
(Pharmacia Uppsala, Sweden) density gradient
centrifugation for 30 min at room temperature.
PBMCs-rich fraction was collected from the
interface and washed twice with Mg2+- and
Ca2+- free phosphate buffered saline (PBS)
(Research Institute for Medical Disease, Osaka,
Japan).  PBMCs were finally resuspended in
Roswell Park Memorial Institute Media 1640 with
25 mmol/L HEPES and 0.3 mmol/L glutamine
(BioWhitker, Walkersville, MD) supplemented
with 10% heat inactivated fetal bovine serum
(FBS) (Cansera International Inc., Rexdale,
ON, Canada), 100 unit/mL penicillin, 100 mg/
mL streptomycin (BioWhitker), and 2 × 10–5
mol/L 2-mercaptoethanol (Wako Life Science
Co., Ltd., Tokyo, Japan ).
Stimulation of PBMCs
PBMCs (1.0 × 106 cells/mL) were stimulated
with phorbol 12-myristate 13-acetate (PMA)
(10 ng/mL) (Wako) and ionomycin (1 μmol/L)
(Sigma, St Louis, MO) in the presence of
brefeldin A (10 μg/mL) (Sigma), in order to
store cytokines at the Golgi complex level, with
or without SNP (0–800 μmol/L) (Wako) at
37˚C under 5% CO2 humidified atmosphere in
24-well microtiter plates (Nunc, Roskilde,
Denmark) for 4, 8 and 12 h.
Concentration of nitrites in supernatants
After 4, 8, and 12 h of stimulation, the super-
natants of the cultured PBMCs were collected
and centrifuged for 5 min at 1500 rpm.  Nitrite
concentration in the supernatants was analyzed
by the Griess method using a commercially
available nitrite/nitrate assay kit-C (Wako).  In
brief, 100 μL of unknown samples and serial
dilution of sodium nitrite standards were added
to the 96-well microtiter plate (Nunc) and then
50 μL of solution A, which consisted of 58
mmol/L of sulfanilamide in 5% phospholic
acid, was added to each well.  After incubating
for 5 min at room temperature, 50 μL of
solution B, which consisted of 3.86 mmol/L of
1-naphthylenediamine, was added to each well
followed by incubating for 10 min at room tem-
perature.  The optic density of each well was
read at 540 nm in a Micro plate reader (Tosoh
Ltd., Tokyo).  The detection range was 10.0–
100 μmol/L of nitrite.
Analysis of cellular viability
Cellular viability was determined by the dye
exclusion test using trypan blue (GIBCO, Grand
Island, NY).  After 8 h of stimulation, cultured
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PBMCs were collected by centrifugation for 5
min at 1500 rpm.  The supernatants were removed
and the cells were resuspended in 1 mL of PBS.
Then, 10 μL of the cell suspension and 10 μL of
0.4% trypan blue were mixed.  The number of
cells in 10 μL of the mixture was counted using
a hemocytometer.  Cellular viability was express-
ed as the percentage of cells excluding the dye
to total inspected cells by the hemocytometer.
Fluorescent staining of cells
The cells were washed twice with PBS and then
resuspended in 50 μL of PBS containing 0.1%
sodium azide (Wako) and 1% FBS (staining
buffer).  Next, they were incubated with 10 μL
of Cy-Chrome conjugated anti-human-CD3
monoclonal antibody (PharMingen, San Diego,
CA) for 30 min in the dark at 4˚C.  Then they
were washed twice in staining buffer, and fixed
throughly with 100 μL of 4% paraformaldehyde
for 20 min in the dark at 4˚C.  After washing
twice with staining buffer, they were resuspended
in 50 μL of PBS containing 0.1% sodium azide,
1% FBS and 0.1% saponin (Sigma) (permeabi-
lization buffer) and incubated with 0.5 μL of
fluorescein isothiocyanate (FITC) conjugated
mouse anti-human IFN-γ IgG1 antibody
(PharMingen) and 1 μL of phycoerythrin (PE)
conjugated mouse anti-human IL-4 IgG2a anti-
body (PharMingen).  For negative control stain-
ing, 0.5 μL of FITC conjugated mouse IgG1
antibody (PharMingen) and 1 μL of PE conju-
gated mouse IgG2a antibody (PharMingen)
were used.  Each tube was incubated for 30 min
in the dark at 4˚C.  Then the cells were washed
twice with permeabilization buffer and
resuspended in staining buffer.
Flow cytometry
Flow cytometry was performed with 1.0 × 106
cells per sample by FACSCalibur (Becton
Dickinson, Mountain View, CA).  It was equipped
with a 15-mW argon ion laser and appropriate
filters for FITC (530 nm), PE (585 nm) and Cy-
Chrome (> 650 nm) were used.  Lymphocytes
were analyzed by selective gating based on
forward and side scatter parameters with CD3
positive cells using CELLQuest software (Becton
Dickinson).  Cytokine-producing cells were
analyzed by detection of FITC and PE staining,
and the results were expressed as the percentage of
cytokine-producing cells in a proportion of CD3
positive lymphocytes.  Statistical markers were set
using an isotype matched negative control.
Morphology of intracellular IFN-γ produc-
ing cells
For immunofluorescent staining of intracellular
IFN-γ, PBMCs were stimulated with PMA and
ionomycin in the presence of brefeldin A for 8 h
and were collected.  After washing with PBS,
the cells were fixed with 100 μL of 4% para-
formaldehyde for 20 min, and then were centri-
fuged for 5 min at 1500 rpm.  Then they were
resuspended in 50 μL of permeabilization buf-
fer and 10 μL of mouse anti-human IFN-γ IgG1
antibody (PharMingen) was added to the cell
suspension and incubated for 30 min in the dark
at 4˚C.  After washing with staining buffer, the
cells were resuspended in 50 μL of permeabili-
zation buffer and incubated with 10 μL of gout
anti-mouse IgG1 FITC antibody (Southern
Biotechnology Associates, Inc., Birmingham,
AL) for 30 min in the dark at 4˚C.  The cells
were washed with permeabilization buffer and
resuspended in staining buffer.  The cells were
transferred to slides and mounted with glycerol
(Wako) and were examined by fluorescence
microscopy (Olympus, Tokyo).
Statistical analysis
Data were presented as mean ± SD.  The results
of the percentage of CD3 antigen expressed
cells, the percentage of intracellular cytokine-
producing cells and nitrite level were shown by
skewed distribution.  Nonparametric analysis
was carried out with the Friedman test for
comparison among multiple groups, and the
Wilcoxon test for differences between the 2
groups.  P values less than 0.05 were considered
to be statistically significant.  These statistical
analyses were performed with the Stat View
4.11 statistics package (Abacus Concepts,
Berkeley, CA).
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Results
Nitrite assay
The nitrite level increased in a time (Fig. 1A)
and a dose dependent manner (Fig. 1B) for SNP
(P = 0.007, P = 0.007, respectively; Friedman
test).  The nitrite level was below any detectable
limit in the supernatants when PBMCs were
cultured without SNP.  After 8 h incubation,
800 μmol/L of SNP released approximately
20.3 μmol/L of nitrite in the culture medium.
Viability assay
The viability of PBMCs was not affected by any
concentrations of SNP without stimulation
from PMA and ionomycin for 8 h (P > 0.05;
Friedman test).  With stimulation from PMA
and ionomycin for 8 h, it was shown to have
diminished the viability of PBMCs (P = 0.001;
Friedman test).  The viability in the presence of
800 μmol/L SNP was significantly diminished
compared with that in the absence of SNP (P =
0.012; Wilcoxon test) (Table 1).
CD3 positive lymphocyte percentage of
PBMC
The mean percentage of CD3 positive lympho-
cytes was 52.1% (range from 44.6% to 64.3%)
(Table 2).  The percentage of CD3 positive
lymphocytes was not affected by stimulation
with PMA and ionomycin, or any concentra-
tions of SNP for 8 h of incubation (P > 0.05;
Friedman test) (Table 2).
Fig. 1.  Concentration of nitrite in the culture medium measured by Griess method.  PBMCs were stimulated
with PMA (10 ng/mL) and ionomycin (1 μmol/L), and SNP was added in the culture medium.  Nitrite level
was measured after 4, 8 and 12 h incubation with 800 μmol/L of SNP (A), and after 8 h incubation with 200,
400 and 800 μmol/L of SNP (B).  Results are expressed as mean ± SD of 4 individual experiments.  Nitrite
level in the culture medium increased significantly in a time and a dose dependent manner for SNP (P = 0.007
and P = 0.007, respectively; Friedman test).
Table 1.  Viability of PBMCs estimated by dye exclusion test using trypan blue
                                  SNP (μmol/L)
0 200 400      800
Without PMA and ionomycin 98.5 ± 1.5% 98.9 ± 1.4% 98.5 ± 1.0% 97.0 ± 3.1%
With PMA and ionomycin 97.1 ± 3.1% 96.8 ± 3.1% 96.1 ± 1.8% 83.2 ± 8.7%
Results are expressed as mean ± SD of 8 individual experiments.
* P = 0.012, between viability of PBMCs in the presence of 800 μmol/L of SNP and in the absence of SNP
when stimulated with PMA and ionomycin (Wilcoxon test).
*
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IFN-γ-staining morphology in individual
cells
Figure 2 shows IFN-γ positive cells which ex-
hibited maximal fluorescence in the cytoplasma
close to the nuclei, reflecting the accumulation
of IFN-γ in the Golgi apparatus.
Flow cytometric analysis of IFN-γ and IL-
4 producing cells
When 800 µmol/L of SNP was added in the
culture medium with stimulation for 8 h, the
percentage of IFN-γ producing cells was
markedly diminished (from 15.2% to 7.7%),
while the percentage of IL-4 producing cells
was diminished slightly (from 2.9% to 2.1%)
(Fig. 3A and B).  Negative staining with isotype
control antibodies is shown in Fig. 3C.
Time course of intracellular IFN-γ and IL-4
staining gated on CD3 positive lympho-
cytes
The percentage of IFN-γ and IL-4 producing
cells in CD3 positive lymphocytes reached
Fig. 2.  Intracellular IFN-γ staining morphology
visualized by fluorescent microscopy.  IFN-γ
producing cells exhibited maximal fluorescence in
the cytoplasma close to the nuclei.
Fig. 3.  Intracellular detection of IFN-γ and IL-4 producing cells gated on CD3 positive lymphocytes from a
healthy subject by flow cytometry.  PBMCs were stimulated with PMA (10 ng/mL) and ionomycin (1 µmol/
L) (A) or together with 800 µmol/L of SNP (B).  Negative staining with isotype control antibodies is shown in
C.  FI, fluorescence intensity.
Table 2.  The percentage of CD3 positive lymphocytes in 1.0 × 104 of PBMCs
      SNP (µmol/L)
0 200 400 800
Without PMA and ionomycin 49.9 ± 3.9% 52.1 ± 6.6% 51.5 ± 6.2% 51.1 ± 5.3%
With PMA and ionomycin 54.8 ± 5.2% 52.7 ± 5.0% 53.2 ± 4.9% 51.5 ± 5.7%
Results are expressed as mean ± SD of 8 individual experiments.
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maximal value at 8 h after stimulation of PMA
and ionomycin without SNP (P < 0.05; Friedman
test).  The percentage of IFN-γ producing cells
in CD3 positive lymphocytes was markedly
diminished by 800 µmol/L of SNP each time.
IL-4 producing cells in CD3 positive lympho-
cytes were also diminished by 800 µmol/L of
SNP each time.  When stimulated for 8 h, the
mean percentage of IFN-γ producing cells in
CD3 positive lymphocytes was 21.9% without
SNP and 12.1% with 800 µmol/L of SNP.
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Fig. 4.  Time course of percentage of intracellular
staining for IFN-γ ( , ) and IL-4 ( , ) with CD3
positive lymphocytes from 4 healthy subjects.
PBMCs were stimulated with PMA (10 ng/mL) and
ionomycin (1 μmol/L) without SNP ( , ) or with
800 μmol/L of SNP ( , ).  The percentage of posi-
tive cells was shown to be the rate of staining cells
by FITC or PE in CD3 positive lymphocytes using
flow cytometry.  Results are expressed as mean ± SD
of 4 individual experiments.  The percentage of IFN-
γ producing cells ( ) and IL-4 producing cells ( )
reached maximal value after 8 h stimulation without
SNP (P < 0.05; Friedman test).  The percentage of
IFN-γ producing cells ( ) and IL-4 producing cells
( ) diminished by SNP at each of the time point.
When stimulated for 8 h, the mean percentage
of IL-4 producing cells in CD3 positive
lymphocytes was 3.4% without SNP and 2.2%
with 800 μmol/L of SNP.  Before stimulation,
the mean percentage of IFN-γ or IL-4 producing
cells in CD3 positive lymphocytes was below
1% (Fig. 4).
The effect of different amounts of SNP
on intracellular IFN-γ and IL-4 producing
lymphocytes
When PBMCs were stimulated with PMA and
ionomycin for 8 h, the percentage of IFN-γ
producing cells gated on CD3 positive lympho-
cytes was diminished by SNP in a dose-
dependent manner (P = 0.002; Friedman test).
The percentage of IFN-γ producing cells in the
presence of 800 μmol/L of SNP was signifi-
cantly diminished compared with that of cells in
the absence of SNP (P = 0.012; Wilcoxon test)
(Fig. 5A).  The percentage of IL-4 producing
cells gated on CD3 positive lymphocytes
tended to be diminished by SNP; however, this
difference was statistically not significant (P =
0.062; Friedman test) (Fig. 5B).
Discussion
We investigated the effects of an NO donor on
the production of IFN-γ and IL-4 at the single
cell level.  When PBMCs were stimulated with
PMA and ionomycin for 8 h, the percentage of
IFN-γ and IL-4 producing cells in CD3 positive
lymphocytes were 21.9% and 3.4%, respective-
ly.  These results were consistent with the obser-
vation of Jung and colleagues (1995).  In the
experiment of co-incubation with SNP, the per-
centage of IFN-γ producing cells diminished
significantly.  While the percentage of IL-4
producing cells tended to be diminished, this
difference, however, was statistically not sig-
nificant.
The viability of PBMCs estimated by the
dye exclusion test using trypan blue was not af-
fected, when 800 μmol/L of SNP was added
without PMA and ionomycin into the culture
medium, while the viability of PBMCs was
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diminished when 800 μmol/L of SNP was
added with PMA and ionomycin into the
culture medium.  So we suggested that SNP had
no cytotoxic effect on PBMCs per se.  SNP was
reported to induce apoptosis of murine neuro-
blastoma (Yamada et al., 1996) and a human
cancer cell line established from squamous cell
carcinoma of the tongue (Sumitani et al., 1997).
The reduction of the viability of PBMCs sti-
mulated with PMA and ionomycin in the pres-
ence of SNP might be partially due to apoptosis.
However, we could have excluded the apoptotic
cells, which were shown to be a lower size than
the living cells (Swat et al., 1991), to be gated
on lymphocytes by forward and side scatter
properties using flow cytometry.  Furthermore,
the percentage of CD3 positive lymphocytes
was not affected by SNP, or PMA and iono-
mycin.  So in all the data obtained from CD3
positive gating, the reduction of the percentage
of IFN-γ producing cells might not result from
cell death or apoptosis.
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The mechanism of the regulating balance
between Th1- and Th2-cytokines has been of
great interest because it may determine the
outcome of allergic and infectious diseases.  It
seemed that NO could play a role in regulating
the development of Th cell differentiation and
could polarize activated T cells to the Th2
profile from ours and other previous reports
(Taylor-Robinson et al., 1994; Chang et al.,
1997).  Asthmatic patients showed elevated
levels of NO in exhaled air (Alving et al., 1993)
and Th2 predominance in the airway or pe-
ripheral blood was reported by several groups
(Rousst et al., 1991; Walker et al., 1992).
Barnes and Liew (1995) speculated that
elevated NO in the asthmatic airway might play
an important role in amplifying and perpetu-
ating Th2 mediated inflammatory response
through inhibition of Th1 mediated immune
response.  Our results may imply that NO in a
local inflammatory site might be attributed to
Th2-dominant inflammation.
The mechanism of the single inhibition of
Th1 cytokine has not yet been understood clear-
ly.  Taylor-Robinson (1997) reported that IL-2
production was inhibited by NO produced from
Th1 cells, and exogenous IL-2 reserved the NO-
mediated down-regulation of Th1 proliferation.
In addition, the inhibition of Th1 cytokines by
NO may represent an important feedback
mechanism preventing overexpression of Th1
cells or excessive production of NO.  Recent
There have been previous reports that exog-
enous NO donors could down-regulate the pro-
duction of IFN-γ and IL-2 (Benbernou et al.,
1997; Taylor-Robinson et al., 1994) as well as
up-regulate the production of IL-4 (Chang et
al., 1997) from T lymphocytes in murine.
Therefore, it has been considered that NO was
one of the modulators of Th cell differentiation
in the murine system as well as in human lympho-
cytes as demonstrated by our results.
A controversial observation to our results
was reported by Bauer and colleagues (1997),
in that the NO donor inhibited both IFN-γ and
IL-4 production from anti-CD3 activated
human T cells.  As to this discrepancy, two
reasons could be considered.  First, NO is pro-
duced and it functions on a micro environmen-
tal level and the half-life of NO is less than 10 s
in vivo (Ignarro, 1990).  And in Bauer’s report,
IL-4 level was estimated by enzyme-linked
immunosorbent assay in the culture supernatant
after one day of stimulation.  Therefore, we
reasoned that our culture system involving a
shorter period of time might be physiologically
relevant to study the effect of NO on T cell
function.  Secondly, Bauer and others used
SIN-1, which releases both NO and superoxide
anion; but NO and superoxide rapidly react to
form peroxynitrite anion.  Peroxynitrite anion
was reported to induce endothelial cell injury
(Beckman et al., 1990) and neuronal cell death
(Lipton et al., 1993).
Fig. 5.  The effect of different amounts of SNP on intracellular IFN-γ (A) and IL-4 staining (B).  PBMCs were
stimulated with PMA (10 ng/mL) and ionomycin (1 μmol/L) with 200, 400, 800 μmol/L of SNP.  Results
were expressed as mean ± SD of 8 individual experiments.  The percentage of IFN-γ producing cells was
significantly diminished by 800 μmol/L of SNP (*P = 0.012; Wilcoxon test).  The percentage of IL-4
producing cells was slightly diminished by SNP, however, statistically not significant (P = 0.062; Friedman
test).
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reports showed intracellular cyclic AMP (c-
AMP) elevating agents, such as PGE2, pentoxifyl-
line and cholera toxin inhibited selectively Th1
cell proliferation or cytokine secretion, while
these agents did not inhibit Th2 proliferation
and production of cytokines (Muñoz et al., 1990;
Betz and Fox, 1991; Benbernou et al., 1995,
1997).  Therefore, it is suggested that c-AMP
and protein kinase A (PKA) pathway, which is
considered to be activated by c-AMP, may play
an important role in determining the balance
between Th1 and Th2 cytokine profiles in T cell
line.  Soff and workers (1997) reported that
SNP activated PKA in rat smooth muscle cells.
Therefore, our results that SNP inhibited Th1
cytokine, but not Th2 cytokine production
might be caused by activation of PKA.  How-
ever, we have no evidence that PKA activation
actually occurred by SNP in lymphocytes.  Fur-
ther study is required to elucidate this hypothe-
sis.
In conclusion, we demonstrated that NO
might affect the diminishing of IFN-γ pro-
duction by lymphocytes, but not significantly
enough to diminish IL-4 production.  Our find-
ings suggest that NO modulates the immune
system by the imbalance of Th1/Th2.
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